(20S)-ginsenoside Rg3 multiple interactions EXP 6480464 ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] CTD PMID:27387537 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of ACP5 protein CTD PMID:17337753 1,4-dichlorobenzene increases expression ISO RGD:10072 6480464 4-dichlorobenzene results in increased expression of ACP5 mRNA CTD PMID:26975756 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:10072 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:30529163 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:10072 6480464 Ethinyl Estradiol results in increased expression of ACP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10072 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:10072 6480464 Ethinyl Estradiol affects the expression of ACP5 mRNA CTD PMID:17555576 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACP5 protein CTD PMID:15917159 17beta-estradiol multiple interactions ISO RGD:10073 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ACP5 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10072 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA, Tetrachlorodibenzodioxin results in increased expression of and results in increased secretion of ACP5 protein CTD PMID:17942748 , PMID:29673856 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ACP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACP5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10072 6480464 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA CTD PMID:17035482 , PMID:21041162 2-aminopurine multiple interactions ISO RGD:10072 6480464 2-Aminopurine inhibits the reaction [[TNF protein co-treated with TNFSF11 protein] results in increased expression of ACP5 protein] CTD PMID:25739386 2-hydroxypropanoic acid decreases expression ISO RGD:10073 6480464 Lactic Acid results in decreased expression of ACP5 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:10072 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of ACP5 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10072 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ACP5 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ACP5 mRNA CTD PMID:25380136 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide multiple interactions ISO RGD:10072 6480464 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:31150804 4-hydroxyphenyl retinamide multiple interactions ISO RGD:10072 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of ACP5 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO RGD:10072 6480464 Fenretinide results in decreased expression of ACP5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:10073 6480464 Decitabine affects the expression of ACP5 mRNA CTD PMID:17145863 acetamide increases expression EXP 6480464 acetamide results in increased expression of ACP5 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:10073 6480464 Aflatoxin B1 results in increased expression of ACP5 mRNA CTD PMID:21641981 aflatoxin B1 decreases expression ISO RGD:10073 6480464 Aflatoxin B1 results in decreased expression of ACP5 mRNA CTD PMID:27153756 alendronic acid multiple interactions EXP 6480464 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein], Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] CTD PMID:27387537 , PMID:29649498 all-trans-retinoic acid increases expression ISO RGD:10072 6480464 Tretinoin results in increased expression of ACP5 mRNA CTD PMID:16604517 aluminium oxide decreases expression ISO RGD:10073 6480464 Aluminum Oxide results in decreased expression of ACP5 mRNA CTD PMID:15585240 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:10072 6480464 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]], pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein] CTD PMID:30580027 aristolochic acid increases expression ISO RGD:10073 6480464 aristolochic acid I results in increased expression of ACP5 mRNA CTD PMID:33212167 azadirachtin A multiple interactions ISO RGD:10072 6480464 azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA] CTD PMID:31225646 azadirachtin A decreases expression ISO RGD:10072 6480464 azadirachtin results in decreased expression of ACP5 mRNA CTD PMID:31225646 beclomethasone decreases activity ISO RGD:10073 6480464 Beclomethasone results in decreased activity of ACP5 protein CTD PMID:8429434 belinostat decreases expression ISO RGD:10073 6480464 belinostat results in decreased expression of ACP5 mRNA CTD PMID:27188386 benzamide multiple interactions ISO RGD:10072 6480464 benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] CTD PMID:29935282 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ACP5 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:10073 6480464 Benzo(a)pyrene affects the methylation of ACP5 5' UTR, Benzo(a)pyrene affects the methylation of ACP5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10073 6480464 Benzo(a)pyrene results in increased expression of ACP5 mRNA CTD PMID:20064835 , PMID:22316170 Bergenin multiple interactions ISO RGD:10072 6480464 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein] CTD PMID:31369791 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACP5 mRNA CTD PMID:25181051 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ACP5 gene CTD PMID:28505145 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of ACP5 protein alternative form CTD PMID:23954550 cadmium atom multiple interactions ISO RGD:10072 6480464 1 more ... CTD PMID:31793751 , PMID:32522522 cadmium dichloride multiple interactions ISO RGD:10072 6480464 [Cadmium Chloride co-treated with TNFSF11] results in increased activity of ACP5 protein, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein CTD PMID:21723911 , PMID:31793751 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ACP5 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:10073 6480464 Calcitriol results in decreased expression of ACP5 protein CTD PMID:21985997 carbon nanotube increases expression ISO RGD:10072 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:10072 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of ACP5 mRNA CTD PMID:23125180 chlorpromazine multiple interactions ISO RGD:10072 6480464 Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:21869564 chlorpyrifos increases expression ISO RGD:10072 6480464 Chlorpyrifos results in increased expression of ACP5 mRNA CTD PMID:32715474 chromium atom decreases activity EXP 6480464 Chromium results in decreased activity of ACP5 protein CTD PMID:16866188 cisapride multiple interactions ISO RGD:10072 6480464 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:31150804 cisplatin increases expression ISO RGD:10073 6480464 Cisplatin results in increased expression of ACP5 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:10073 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ACP5 mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:10072 6480464 Clofibrate results in decreased expression of ACP5 mRNA CTD PMID:17585979 copper(II) sulfate decreases expression ISO RGD:10073 6480464 Copper Sulfate results in decreased expression of ACP5 mRNA CTD PMID:19549813 crocin-1 multiple interactions ISO RGD:10072 6480464 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]] CTD PMID:30580027 cyclosporin A multiple interactions ISO RGD:10072 6480464 Cyclosporine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 cyclosporin A decreases expression ISO RGD:10073 6480464 Cyclosporine results in decreased expression of ACP5 mRNA CTD PMID:27989131 desferrioxamine B multiple interactions ISO RGD:10072 6480464 Deferoxamine inhibits the reaction [TF protein results in increased activity of ACP5 protein], TF protein inhibits the reaction [Deferoxamine results in decreased activity of ACP5 protein] CTD PMID:31238089 desferrioxamine B decreases activity ISO RGD:10072 6480464 Deferoxamine results in decreased activity of ACP5 protein CTD PMID:31238089 dexamethasone multiple interactions ISO RGD:10073 6480464 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein CTD PMID:16079895 dexamethasone increases activity EXP 6480464 Dexamethasone results in increased activity of ACP5 protein CTD PMID:27387537 , PMID:28363435 dexamethasone multiple interactions EXP 6480464 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] more ... CTD PMID:27387537 , PMID:28363435 dexamethasone increases expression ISO RGD:10072 6480464 Dexamethasone results in increased expression of ACP5 mRNA CTD PMID:21041162 diethylstilbestrol increases expression ISO RGD:10072 6480464 Diethylstilbestrol results in increased expression of ACP5 mRNA CTD PMID:21041162 diosgenin multiple interactions ISO RGD:10072 6480464 Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:16331273 dithionite(2-) decreases activity EXP 6480464 Dithionite results in decreased activity of ACP5 protein CTD PMID:6886379 dithionite(2-) multiple interactions EXP 6480464 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] CTD PMID:6886379 diuron increases expression EXP 6480464 Diuron results in increased expression of ACP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:10073 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:10073 6480464 Doxorubicin results in decreased expression of ACP5 mRNA CTD PMID:29803840 ellagic acid multiple interactions ISO RGD:10072 6480464 Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA], Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:32971123 entinostat increases expression ISO RGD:10073 6480464 entinostat results in increased expression of ACP5 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:10073 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:10072 6480464 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] CTD PMID:22892342 ethanol increases expression ISO RGD:10072 6480464 Ethanol results in increased expression of ACP5 mRNA CTD PMID:22892342 fluoxetine multiple interactions ISO RGD:10072 6480464 Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:15312242 furan increases expression EXP 6480464 furan results in increased expression of ACP5 mRNA CTD PMID:25539665 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ACP5 mRNA CTD PMID:12075121 genistein multiple interactions ISO RGD:10072 6480464 [Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA CTD PMID:17295206 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACP5 mRNA CTD PMID:22061828 guanethidine affects expression EXP 6480464 Guanethidine affects the expression of ACP5 protein CTD PMID:14527964 guanethidine increases expression EXP 6480464 Guanethidine results in increased expression of ACP5 mRNA CTD PMID:14527964 Heptachlor epoxide increases expression ISO RGD:10072 6480464 Heptachlor Epoxide results in increased expression of ACP5 mRNA CTD PMID:25270620 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of ACP5 mRNA CTD PMID:25972201 iron dichloride multiple interactions EXP 6480464 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] CTD PMID:6886379 ivermectin decreases expression ISO RGD:10073 6480464 Ivermectin results in decreased expression of ACP5 protein CTD PMID:32959892 KN-93 multiple interactions ISO RGD:10072 6480464 KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein] CTD PMID:32522522 linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of ACP5 protein CTD PMID:28086193 lipopolysaccharide multiple interactions ISO RGD:10072 6480464 CSF1R affects the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:22067001 , PMID:30048646 lipopolysaccharide increases expression ISO RGD:10072 6480464 Lipopolysaccharides results in increased expression of ACP5 mRNA, Lipopolysaccharides results in increased expression of ACP5 protein CTD PMID:22067001 , PMID:30048646 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ACP5 mRNA CTD PMID:22281203 , PMID:28801915 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of ACP5 gene CTD PMID:28801915 mangiferin multiple interactions ISO RGD:10072 6480464 mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:20683903 Maxacalcitol decreases expression ISO RGD:10073 6480464 maxacalcitol results in decreased expression of ACP5, maxacalcitol results in decreased expression of ACP5 protein CTD PMID:11576942 , PMID:8840326 methylglyoxal increases expression EXP 6480464 Pyruvaldehyde results in increased expression of ACP5 mRNA, Pyruvaldehyde results in increased expression of ACP5 protein CTD PMID:31103701 methylglyoxal multiple interactions ISO RGD:10072 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde] affects the activity of ACP5 protein more ... CTD PMID:30217477 more ... methylglyoxal increases expression ISO RGD:10072 6480464 Pyruvaldehyde results in increased expression of ACP5 mRNA CTD PMID:31103701 modafinil multiple interactions EXP 6480464 Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] CTD PMID:29649498 modafinil increases expression EXP 6480464 modafinil results in increased expression of ACP5 mRNA, modafinil results in increased expression of ACP5 protein CTD PMID:29649498 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ACP5 mRNA CTD PMID:16026605 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ACP5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ACP5 mRNA CTD PMID:25380136 naringin multiple interactions ISO RGD:10072 6480464 naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA], naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein] CTD PMID:21835177 , PMID:24376342 naringin decreases expression ISO RGD:10072 6480464 naringin results in decreased expression of ACP5 mRNA CTD PMID:24376342 niclosamide multiple interactions ISO RGD:10073 6480464 Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:26792726 niclosamide multiple interactions ISO RGD:10072 6480464 Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] CTD PMID:28824321 nitric acid increases expression EXP 6480464 Nitric Acid results in increased expression of ACP5 protein CTD PMID:16436523 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ACP5 mRNA CTD PMID:33484710 NMN zwitterion multiple interactions EXP 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of ACP5 protein] CTD PMID:30292833 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ACP5 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:10072 6480464 Acetaminophen affects the expression of ACP5 mRNA CTD PMID:17562736 phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] CTD PMID:28363435 poly(ethylene) decreases expression ISO RGD:10073 6480464 Polyethylene results in decreased expression of ACP5 mRNA CTD PMID:15585240 poly(methyl methacrylate) macromolecule multiple interactions ISO RGD:10072 6480464 naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein], Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein CTD PMID:24376342 potassium dichromate decreases activity EXP 6480464 Potassium Dichromate results in decreased activity of ACP5 protein CTD PMID:16866188 rac-lactic acid decreases expression ISO RGD:10073 6480464 Lactic Acid results in decreased expression of ACP5 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:10073 6480464 resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] CTD PMID:16267019 rotenone multiple interactions ISO RGD:10073 6480464 Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:19900598 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ACP5 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:10072 6480464 4-(5-benzo(1 more ... CTD PMID:29127033 SB 431542 multiple interactions ISO RGD:10073 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sclareol decreases expression ISO RGD:10072 6480464 sclareol results in decreased expression of ACP5 mRNA, sclareol results in decreased expression of ACP5 protein CTD PMID:33423118 sclareol multiple interactions ISO RGD:10072 6480464 sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA], sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:33423118 silicon dioxide increases expression ISO RGD:10073 6480464 Silicon Dioxide analog results in increased expression of ACP5 mRNA CTD PMID:23806026 , PMID:25895662 silicon dioxide increases expression ISO RGD:10072 6480464 Silicon Dioxide results in increased expression of ACP5 mRNA CTD PMID:29341224 sodium arsenite multiple interactions ISO RGD:10072 6480464 [NFE2L2 protein affects the susceptibility to sodium arsenite] which affects the expression of ACP5 protein CTD PMID:30742845 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ACP5 mRNA CTD PMID:22561333 sodium fluoride decreases expression ISO RGD:10072 6480464 Sodium Fluoride results in decreased expression of ACP5 protein CTD PMID:29127033 sodium fluoride multiple interactions ISO RGD:10072 6480464 4-(5-benzo(1 more ... CTD PMID:29127033 , PMID:32156525 sodium fluoride increases expression ISO RGD:10072 6480464 Sodium Fluoride results in increased expression of ACP5 mRNA CTD PMID:29127033 , PMID:32156525 Soman increases expression EXP 6480464 Soman results in increased expression of ACP5 mRNA CTD PMID:19281266 stevioside decreases secretion EXP 6480464 stevioside results in decreased secretion of ACP5 protein CTD PMID:21089163 succimer multiple interactions ISO RGD:10072 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane increases expression ISO RGD:10072 6480464 sulforaphane results in increased expression of ACP5 mRNA CTD PMID:30529165 tacrolimus hydrate multiple interactions ISO RGD:10072 6480464 Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 testosterone increases expression EXP 6480464 Testosterone results in increased expression of ACP5 mRNA CTD PMID:15917159 tetrachloromethane decreases expression ISO RGD:10072 6480464 Carbon Tetrachloride results in decreased expression of ACP5 mRNA CTD PMID:31919559 thalidomide multiple interactions ISO RGD:10073 6480464 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein CTD PMID:16079895 theophylline increases expression EXP 6480464 Theophylline results in increased expression of ACP5 mRNA, Theophylline results in increased expression of ACP5 protein CTD PMID:26851681 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ACP5 mRNA CTD PMID:23411599 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA CTD PMID:28943392 thymol multiple interactions ISO RGD:10072 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:30048646 thymol sulfate(1-) multiple interactions ISO RGD:10072 6480464 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA] more ... CTD PMID:30048646 titanium dioxide decreases expression ISO RGD:10072 6480464 titanium dioxide results in decreased expression of ACP5 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ACP5 mRNA CTD PMID:25729387 tungsten multiple interactions ISO RGD:10072 6480464 Tungsten promotes the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] CTD PMID:33146397 uranium atom increases expression EXP 6480464 Uranium results in increased expression of ACP5 protein CTD PMID:16436523 uranium atom multiple interactions EXP 6480464 GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein] CTD PMID:29477364 uranium atom increases secretion EXP 6480464 Uranium results in increased secretion of ACP5 protein CTD PMID:29477364 valproic acid affects expression ISO RGD:10072 6480464 Valproic Acid affects the expression of ACP5 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:10073 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:10073 6480464 Valproic Acid results in increased expression of ACP5 mRNA CTD PMID:23179753 , PMID:26272509 valproic acid decreases expression ISO RGD:10073 6480464 Valproic Acid results in decreased expression of ACP5 mRNA CTD PMID:29154799 venlafaxine hydrochloride decreases expression ISO RGD:10073 6480464 Venlafaxine Hydrochloride results in decreased expression of ACP5 mRNA CTD PMID:16341940 vitamin D multiple interactions ISO RGD:10072 6480464 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] CTD PMID:22892342 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ACP5 mRNA CTD PMID:21893222 zinc atom decreases activity EXP 6480464 Zinc deficiency results in decreased activity of ACP5 protein CTD PMID:21893222 zinc sulfate multiple interactions ISO RGD:10072 6480464 [Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA more ... CTD PMID:17295206 , PMID:18636177 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ACP5 mRNA CTD PMID:21893222 zinc(0) decreases activity EXP 6480464 Zinc deficiency results in decreased activity of ACP5 protein CTD PMID:21893222
